Teucvidin is primarily studied for its potential anti-cancer properties, particularly in the context of inducing apoptosis in tumor cells. It has shown activity against various cancer cell lines by interfering with cell cycle progression and promoting mitochondrial dysfunction in malignant cells. Its ability to act as a sesquiterpene lactone contributes to its cytotoxic effects, making it a candidate for further research in oncology drug development. Additionally, teucvidin exhibits anti-inflammatory and immunomodulatory effects, suggesting possible use in treating chronic inflammatory conditions. Research remains largely preclinical, focusing on its mechanisms of action and potential for structural optimization to improve bioavailability and therapeutic efficacy.